全球精準醫學軟體市場：非凡見解（2024-2029）

預計2023年至2029年全球精準醫療市場規模將以12.60%的年複合成長率擴大。

精準醫療致力於個人化治療，目的是利用資料驅動的見解在正確的時間向正確的患者提供正確的藥物。機器學習和人工智慧等新興技術將透過將醫療決策轉化為準確的早期疾病分類、個人化治療途徑和預測模型來增強這種方法。癌症研究的主要挑戰是透過評估基因組內的致癌突變來確定有效的治療方法。像美國 OncXerna 這樣的新創公司建立 RNA 表達生物標記面板等創新研究平台，以根據 RNA 特徵將患者與治療匹配，超越所採用的標準方法。儘管取得了進步，但目前的精準醫療解決方案通常側重於靶向癌細胞，而不是改善患者的整體健康。為了解決這個問題，以色列新創公司 AceTech 等公司開發用於主動支持護理的軟體，在症狀出現之前治療癌症。

在軟體和製藥公司之間合作夥伴關係增加的推動下，圍繞醫療保健的環境迅速發展。這些合作變得越來越普遍，因為兩個行業都認識到將先進技術和製藥專業知識相結合以改善藥物開發、患者護理和結果的互惠互利。製藥公司依靠軟體解決方案來簡化藥物發現、開發和製造流程。同時，軟體公司將先進的分析、人工智慧（AI）和機器學習技術整合到藥物研究中，以提高藥物發現的準確性和效率。透過分析巨量資料集，這些技術可以識別潛在的新藥候選物，預測其有效性，並減少將新藥推向市場的時間和成本。

人工智慧和生物資訊等先進軟體技術的採用徹底改變精準醫療。該平台同時分析複雜的基因-藥物和藥物-藥物交互作用，實現更個人化的治療計劃。透過利用人工智慧和巨量資料分析，GenMedPro 促進即時基因組資料分析，以提高複雜疾病治療決策的準確性。精準醫療軟體，尤其是腫瘤學領域的軟體，利用人工智慧快速分析基因報告，以確保對患有複雜健康狀況的患者進行及時有效的治療。這一趨勢清楚地表明了技術如何透過基於全面遺傳見解的個人化治療來最佳化治療結果。

本報告考察了全球精準醫療軟體市場，提供市場概況，依部署、應用、最終用戶、地區的趨勢以及參與市場的公司概況。

目錄

第1章 精準醫療軟體市場概論

第2章 精準醫療軟體市場

• 全球精準醫療軟體市場收入預測（2020-2029年，百萬美元）

第3章 精準醫療軟體市場細分資料

• 依部署劃分的全球收入預測（2020-2029年，百萬美元）
  • 本地
  • 雲端
• 依應用的全球收入預測（2020-2029年，百萬美元）
  • 精準腫瘤學
  • 藥物基因組學
  • 罕見疾病
  • 其他
• 全球收入預測，依最終用戶劃分（2020-2029年，百萬美元）
  • 醫療保健提供者
  • 研究實驗室
  • 製藥和生技公司

第4章 主要地區概況

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東、非洲

第5章 精準醫療軟體市場前景與機會

第6章 精準醫療軟體產業概論

• 精準醫療軟體市場 - 競爭格局
• 精準醫療軟體市場 - 主要供應商概況
• 精準醫療軟體市場 - 其他主要供應商
• 精準醫療軟體市場 - 關鍵策略建議

第7章 附錄

The global precision medicine software market is expected to grow at a CAGR of 12.60% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Leveraging AI and Machine Learning for Personalized Treatment and Cancer Research

Precision medicine focuses on personalized treatments, aiming to deliver the right medication to the right patient at the right time using data-driven insights. Emerging technologies like machine learning and AI enhance this approach by transforming medical judgments into precise, early disease classification, personalized treatment pathways, and predictive modeling. In cancer research, a major challenge is identifying effective treatments by evaluating cancer-causing mutations within the genome. Start-ups, like US-based OncXerna, are creating innovative research platforms, such as RNA expression biomarker panels, to match patients with treatments based on RNA signatures, moving beyond a one-size-fits-all approach. Despite advancements, current precision medicine solutions often focus on targeting cancer cells rather than improving overall patient health. To address this, companies like Israeli start-up AceTech are developing software for proactive, supportive care to treat cancers before symptoms appear.

Increased Partnerships Among Software and Pharmaceutical Companies

The healthcare landscape is evolving rapidly, driven by the increasing collaboration between software and pharmaceutical companies. These partnerships are becoming more prevalent as both sectors recognize the mutual benefits of combining advanced technology with pharmaceutical expertise to enhance drug development, patient care, and treatment outcomes. Pharmaceutical companies leverage software solutions to streamline drug discovery, development, and manufacturing processes. On the other hand, software companies are integrating their advanced analytics, artificial intelligence (AI), and machine learning technologies with pharmaceutical research to improve the accuracy and efficiency of drug discovery. By analyzing large datasets, these technologies can identify potential drug candidates, predict their efficacy, and reduce the time and cost of bringing new drugs to market.

The Rising Adoption of Biocompatible Synthetic Bone Grafts And Biologics

Adopting advanced software technologies like AI and bioinformatics is revolutionizing precision medicine. A key example is the launch of Genomind's GenMedPro in February 2024, a platform that simultaneously analyzes complex gene-drug and drug-to-drug interactions, enabling more personalized treatment plans. By utilizing AI and big data analytics, GenMedPro facilitates real-time genomics data analysis, improving precision in treatment decisions for complex diseases. Precision medicine software, particularly in oncology, leverages AI to analyze genetic reports swiftly, ensuring timely and effective treatment for patients with intricate health conditions. This trend underscores how technology optimizes treatment outcomes through individualized care based on comprehensive genetic insights. Beyond oncology, personalized treatment is gaining traction in other therapeutic areas, supported by significant investments. For instance, in January 2024, Sano Genetics raised USD 11.4 million, led by Plural, for its precision medicine software platform, which is crucial for running clinical trials, reflecting growing financial interest in this sector.

INDUSTRY RESTRAINTS

High Cost Associated with Implementation And Integration

A major challenge for the global precision medicine software market is the high cost and complexity of implementation. Precision medicine relies on managing vast amounts of genomic and clinical data, requiring sophisticated software. Healthcare organizations face obstacles like interoperability issues when integrating new systems with existing infrastructure and data privacy and security concerns. Additionally, extensive training for healthcare professionals adds complexity, and the financial burden of acquiring and maintaining this software can be prohibitive, especially for smaller institutions and resource-constrained regions, limiting the adoption of precision medicine technologies.

SEGMENTATION INSIGHTS

INSIGHTS BY DEVELOPMENT

The global precision medicine software market by development is segmented into on-premises and cloud-based. The on-premises segment accounted for the largest market share in 2023. The ongoing revolution in healthcare data drives the demand for robust data storage solutions that ensure data security, facilitate access, and enable innovative solutions derived from this data. Hospitals and clinics must rapidly process patient data, such as medical images, to provide timely diagnoses. Similarly, research labs generate terabytes of data that must be managed on-premises, as transmitting it to the cloud for processing is inefficient. These applications must run locally to meet the demands of real-time data processing and high throughput. The broad advantages of on-premises software, such as enhanced data security, reduced risk of data breaches, and full control over software upgrades and data storage, contribute to its popularity and growth.

By Deployment

• On-premises
• Cloud-based

INSIGHTS BY APPLICATION

The global precision medicine software market by application is categorized into precision oncology, pharmacogenomics, rare diseases, and others. The precision oncology segment shows significant growth, with the fastest-growing CAGR of 13.29% during the forecast period. Cancer treatment is the primary application of precision medicine software, fueled by rising global cancer rates and the increasing use of genomics to develop personalized therapies. The precision medicine software market is growing rapidly, driven by data analytics and AI advancements. Platforms like Epigene Labs' mCUBE accelerate drug discovery by integrating biomarker identification with AI algorithms, which enhances oncology patient outcomes. These innovations in precision medicine software, particularly in precision oncology, make cancer treatment more efficient and accessible.

By Application

• Precision Oncology
• Pharmacogenomics
• Rare Diseases
• Others

INSIGHTS BY END-USER

Based on the end-user, the healthcare providers accounted for the largest share of the global precision medicine software market, accounting for over 49% in 2023. Healthcare providers are at the forefront of patient care. As healthcare providers increasingly adopt genomic sequencing, molecular diagnostics, and other advanced technologies, precision medicine software becomes essential for managing and analyzing vast amounts of patient-specific data. Thus, integrating precision medicine into clinical decision-making has become a game-changer. Leveraging artificial intelligence (AI) and machine learning (ML) tools, healthcare systems such as Tufts Medicine have utilized cloud-based platforms like Amazon Web Services to enhance access to patient data. These technologies allow healthcare providers to make personalized treatment plans based on genetic, lifestyle, and environmental factors, helping segmental growth.

By End-User

• Healthcare Providers
• Research Labs
• Pharma & Biotech Companies

GEOGRAPHICAL ANALYSIS

North America dominates with the largest global precision medicine software market share. The growth is driven by the increasing adoption of healthcare information technologies (HCITs) and the growing use of information and communication technology (ICT) by healthcare providers and research communities. One of the primary reasons behind this leadership is the region's emphasis on personalized medicine to address a wide range of rare and highly complex diseases. Following the completion of the Human Genome Project, North America, particularly the United States, has made remarkable strides in genome sequencing and precision medicine. These advancements, combined with innovations in ICT and big data analytics, have revolutionized the development of cell and gene therapies. This is especially significant in areas like oncology and rare diseases, where personalized treatments are becoming more effective and accessible.

By Geography

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

COMPETITIVE LANDSCAPE

The global precision medicine software market report contains exclusive data on 24 vendors. The market is highly competitive and rapidly evolving, with numerous established players and new entrants shaping its landscape. Key players include Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel Corp, and International Business Machines. These companies offer a range of precision medicine software solutions for genomics analysis, clinical decision support, data integration, and patient engagement. Integrating AI and machine learning into precision medicine software enables better data analysis and patient-specific treatment options, fostering growth and innovation. Major players constantly upgrade their platforms to incorporate advanced analytics and automation, making them more attractive to healthcare providers and researchers.

Key Vendors

• Syapse
• AccessDX Laboratory
• Fabric Genomics
• Foundation Medicine
• Intel Corp
• International Business Machines

Other Prominent Vendors

• Qiagen
• PhenoTips
• GenomOncology
• NantHealth
• Koninklijke Philips
• Sophia Genetics
• Roper Technologies
• PierianDx
• Fountain Life
• Flatiron Health
• Tempus
• Illumina
• Molecular Health
• Human Longevity
• Ariel Precision Medicine
• Veracyte
• Genedata
• Inspirata

KEY QUESTIONS ANSWERED:

1. Which region dominates the global precision medicine software market?

2. How big is the global precision medicine software market?

3. What is the growth rate of the global precision medicine software market?

4. Who are the major players in the global precision medicine software market?

TABLE OF CONTENTS

CHAPTER - 1: Precision Medicine Software Market Overview

• Executive Summary
• Key Findings

CHAPTER - 2: Precision Medicine Software Market

• GLOBAL: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)

CHAPTER - 3: Precision Medicine Software Market Segmentation Data

• GLOBAL: Projected Revenue by Deployment (2020-2029; $Millions)
  • On-premises
  • Cloud-based
• GLOBAL: Projected Revenue by Application (2020-2029; $Millions)
  • Precision Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Others
• GLOBAL: Projected Revenue by End-User (2020-2029; $Millions)
  • Healthcare Providers
  • Research Labs
  • Pharma & Biotech Companies

CHAPTER - 4: Key Regions Overview

• North America: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
  • Projected Revenue of Precision Medicine Software Market in US
  • Projected Revenue of Precision Medicine Software Market in Canada
• Europe: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
  • Projected Revenue of Precision Medicine Software Market in Germany
  • Projected Revenue of Precision Medicine Software Market in France
  • Projected Revenue of Precision Medicine Software Market in UK
  • Projected Revenue of Precision Medicine Software Market in Italy
  • Projected Revenue of Precision Medicine Software Market in Spain
• APAC: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
  • Projected Revenue of Precision Medicine Software Market in China
  • Projected Revenue of Precision Medicine Software Market in Japan
  • Projected Revenue of Precision Medicine Software Market in India
  • Projected Revenue of Precision Medicine Software Market in Australia
  • Projected Revenue of Precision Medicine Software Market in South Korea
• Latin America: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
  • Projected Revenue of Precision Medicine Software Market in Brazil
  • Projected Revenue of Precision Medicine Software Market in Mexico
  • Projected Revenue of Precision Medicine Software Market in Argentina
• Middle East & Africa: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
  • Projected Revenue of Precision Medicine Software Market in Turkey
  • Projected Revenue of Precision Medicine Software Market in Saudi Arabia
  • Projected Revenue of Precision Medicine Software Market in South Africa

CHAPTER - 5: Precision Medicine Software Market Prospects & Opportunities

• Precision Medicine Software Market Opportunities & Trends
• Precision Medicine Software Market Drivers
• Precision Medicine Software Market Constraints

CHAPTER - 6: Precision Medicine Software Industry Overview

• Precision Medicine Software Market - Competitive Landscape
• Precision Medicine Software Market - Key Vendor Profiles
• Precision Medicine Software Market - Other Prominent Vendors
• Precision Medicine Software Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

• Research Methodology
• Abbreviations
• About Arizton

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of Global Precision Medicine Software (2020-2029, $ MN)

Exhibit 2: Market Size & Forecast - On-premises (2020-2029, $ MN)

Exhibit 3: Market Size & Forecast - Cloud-based (2020-2029, $ MN)

Exhibit 4: Exhibit 1: Market Size & Forecast - Precision Oncology (2020-2029, $ MN)

Exhibit 5: Market Size & Forecast - Pharmacogenomics (2020-2029, $ MN)

Exhibit 6: Market Size & Forecast - Rare Diseases (2020-2029, $ MN)

Exhibit 7: Market Size & Forecast - Others (2020-2029, $ MN)

Exhibit 8: Market Size & Forecast - Healthcare Facilities (2020-2029, $ MN)

Exhibit 9: Market Size & Forecast - Research Labs (2020-2029, $ MN)

Exhibit 10: Market Size & Forecast - Pharma & Biotech Companies (2020-2029, $ MN)

Exhibit 11: Projected Revenues of Precision Medicine Software in North America (2020-2029, $ MN)

Exhibit 12: Projected Revenues of Precision Medicine Software in the US (2020-2029,$ MN)

Exhibit 13: Projected Revenues of Precision Medicine Software in Canada (2020-2029, $ MN)

Exhibit 14: Projected Revenues of Precision Medicine Software in Europe (2020-2029, $ MN)

Exhibit 15: Projected Revenues of Precision Medicine Software in Germany (2020-2029, $ MN)

Exhibit 16: Projected Revenues of Precision Medicine Software in France (2020-2029, $ MN)

Exhibit 17: Projected Revenues of Precision Medicine Software in the UK (2020-2029, $ MN)

Exhibit 18: Projected Revenues of Precision Medicine Software in Italy (2020-2029, $ MN)

Exhibit 19: Projected Revenues of Precision Medicine Software in Spain (2020-2029, $ MN)

Exhibit 20: Projected Revenues of Precision Medicine Software in APAC (2020-2029, $ MN)

Exhibit 21: Projected Revenues of Precision Medicine Software in China (2020-2029, $ MN)

Exhibit 22: Projected Revenues of Precision Medicine Software in Japan (2020-2029, $ MN)

Exhibit 23: Projected Revenues of Precision Medicine Software in India (2020-2029, $ MN)

Exhibit 24: Projected Revenues of Precision Medicine Software in Australia (2020-2029, $ MN)

Exhibit 25: Projected Revenues of Precision Medicine Software in South Korea (2020-2029, $ MN)

Exhibit 26: Projected Revenues of Precision Medicine Software in Latin America (2020-2029, $ MN)

Exhibit 27: Projected Revenues of Precision Medicine Software in Brazil (2020-2029, $ MN)

Exhibit 28: Projected Revenues of Precision Medicine Software in Mexico (2020-2029, $ MN)

Exhibit 29: Projected Revenues of Precision Medicine Software in Argentina (2020-2029, $ MN)

Exhibit 30: Projected Revenues of Precision Medicine Software in the MEA (2020-2029, $ MN)

Exhibit 31: Projected Revenues of Precision Medicine Software in Turkey (2020-2029, $ MN)

Exhibit 32: Projected Revenues of Precision Medicine Software in Saudi Arabia (2020-2029, $ MN)

Exhibit 33: Projected Revenues of Precision Medicine Software in South Africa (2020-2029, $ MN)

LIST OF TABLES

LIST OF TABLES

Table 1: Projected Revenues of Global Precision Medicine Software Market (2020-2029, $ MN)

Table 2: Global Precision Medicine Software Market by Deployment (2020-2029, %)

Table 3: Global Precision Medicine Software Market by Deployment (2020-2029, $ MN)

Table 4: Global Precision Medicine Software Market by Application (2020-2029, %)

Table 5: Global Precision Medicine Software Market by Application (2020-2029, $ MN)

Table 6: Global Precision Medicine Software Market by End-User (2020-2029, %)

Table 7: Global Precision Medicine Software Market by End-User (2020-2029, $ MN)

Table 8: Global Precision Medicine Software Market by Geography (2020-2029, %)

Table 9: Global Precision Medicine Software Market by Geography (2020-2029, $ MN)